Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

This trial is being conducted to evaluate the efficacy of Phasix Mesh implantation at the
time of midline fascial closure compared to primary suture closure in preventing a subsequent
incisional hernia in subjects at risk for incisional hernia after open midline laparotomy
surgery.

Disease Sites:

Miscellaneous

Staging:

Phase IV

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Pierce, Richard

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

06-09-2020

Trial Type:

Prevention

Protocol ID:

VICCGI2281

National Clinical Trial ID:

NCT03911700

View Internal Documents

Eligibility

Ages Eligible for Study:

18 Years

Genders Eligible for Study:

BOTH

Accepts Healthy Volunteers?:

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Eligibility